Anti-Jo-1

Alphabetical Test listing

Anti-Jo-1-13408

  
Anti-Jo-1
  
13408
  
LAB13408
  
JO1
  
Polymyositis
t-RNA synthetase
  

Evaluate patients suspected of having polymyositis, dermatomyositis, or polymyositis-scleroderma overlap syndrome.

  
Serum
  
  
0.6 mL
  
0.3 mL
  

Immediatley following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  
  
  1. Allow sample to clot
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
  
  

Ambient (preferred) - 14 days

Refrigerated - 14 days

Frozen - 14 days

Freeze/thaw cycles - stable x 3

  
  • Hemolysis
  • Icterus
  • Lipemia
  • Bacterial contamination
  
LabCorp Burlington (161455): R-LC
  
Mo - Sa
  
1 - 3 days
  

Multiplex flow immunoassay

  

0.0 - 0.9 AI

  

Anti-Jo-1 antibodies are present in approximately 20% to 30% of patients with adult-onset polymyositis syndromes. They are present in >65% of patients with both myositis and interstitial lung disease. In such patients, the presence of anti-Jo-1 antibodies may be predictive of a response to steroid treatment. Testing for ANAs is not adequate for the detection of anti-Jo-1 antibodies.

  
86235
  
Result 11565-9
  
03/27/2019
  
03/29/2021
  
12/31/2023